Clinical trial
Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes
NCT00497198 · Tanabe Pharma Corporation, Industry · Completed
Key facts
| NCT number | NCT00497198 |
|---|---|
| Title | Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes |
| Official title | An Exploratory Study of MCI-196 for Treatment of Type 2 Diabetes in Randomized, Double-Blind, Parallel-Assignment, Placebo-Controlled Manner |
| Lead sponsor | Tanabe Pharma Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | MCI-196, Placebo of MCI-196 Tablet |
| Enrollment | 183 |
| Start date | Oct 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Jul 6, 2007 |
| Last update posted | Jan 6, 2026 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: